Here's the June 2015 backgrounder; and here's today's denouement of that story, and a bit:
. . . .A spokesperson for the company confirmed something that is already posted to the US public clinical trials registry.
“Merck has decided to stop further clinical development of MK-6018 (CM-24). In the initial Phase 1 dose-ranging study, no efficacy signals were detected. The decision to discontinue further development is not due to any known safety risks.”
And there goes a deal completed with a $95 million upfront and $510 million in milestones that won’t get paid. . . .
![](https://anewmerckreviewed.files.wordpress.com/2015/06/c7bec-mrk-obamacare-june-2015.png)
In short, he is unfit to govern, since he doesn't even understand (or care to discern) which ones might be the right questions to ask. Mr. Ryan bears responsibility here too -- but it is hilarious that Mr. Trump is blaming Democrats for the defeat of his ill-starred OrangeCare lunacy. He won in a sweep, in November -- and as the ides of March arrive -- he cannot even get his own party to agree on what they ran on. Hilarious -- but this has nothing to do with Democrats, or even to do with ObamaCare. . . it is an epic internal failure of the GOP. After all, the ACA of 2010 passed without a single GOP vote. So 45 looks foolish, again. [I might look for a renewed effort in 2018, after the mid-terms. End, updated portion.]
Moving on, then -- getting out, for a long garden lunch, on a flawless 80 degree Friday. . . . yep. I'm out. Be excellent to someone who may not. . . deserve it.
नमस्ते
1 comment:
Once more, from Singapore… 1:22 in the morning now, miss.
Luminous yet clear…
Cheers!
Post a Comment